Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
ES16 - Joint Global Lung Cancer Coalition/IASLC Session: Hot Topics for Advocates
- 14:15 - 15:15
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Patient Advocacy
-
+
ES16.01 - Chair
14:15 - 14:15 | Presenter: Matthew Peters
- Abstract
No abstract available for this presentation
-
+
ES16.02 - Chair
14:15 - 14:15 | Presenter: Satoko Kono Yamaoka
- Abstract
No abstract available for this presentation
-
+
ES16.03 - Pro – New Trend and Tool
14:15 - 14:27 | Presenter: Kazuo Hasegawa
- Abstract
No abstract available for this presentation
-
+
ES16.04 - Campaigning for Lung Cancer Screening - A Tool for Advocates
14:27 - 14:39 | Presenter: Sarah Elizabeth Winstone
- Abstract
Loading... -
+
ES16.06 - Insights in Global Lung Cancer Patient Experience
14:39 - 14:51 | Presenter: Lillian Leigh
- Abstract
Loading... -
+
ES16.07 - Live Q&A
14:51 - 15:15
- Abstract
No abstract available for this presentation
-
+
MA06 - Molecular Developments and Novel Treatments in Mesothelioma and Thymoma
- 14:15 - 15:15
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
MA06.01 - Chair
14:15 - 14:15 | Presenter: Harvey I. Pass
- Abstract
No abstract available for this presentation
-
+
MA06.02 - Chair
14:15 - 14:15 | Presenter: Joachim Aerts
- Abstract
No abstract available for this presentation
-
+
MA06.03 - Phosphorylated Ribosomal Protein S6, Correlation With Characteristics and Clinical Outcome in Patients With MPM: Results from ETOP Mesoscape
14:15 - 14:20 | Presenter: Isabelle Opitz
- Abstract
Loading... -
+
MA06.04 - FGF5 Expression in Malignant Pleural Mesothelioma: Impact on Cell Growth, Cisplatin Resistance and Patient Survival
14:20 - 14:25 | Presenter: Michael Grusch
- Abstract
Loading... -
+
MA06.05 - Targeting Anti-Apoptotic Mechanisms in Malignant Pleural Mesothelioma
14:25 - 14:30 | Presenter: Ren-Wang Peng
- Abstract
Loading... -
+
MA06.06 - Intracavitary Cisplatin-Fibrin followed by Irradiation after Lung Sparing Surgery in a Rat Model of Malignant Mesothelioma
14:30 - 14:35 | Presenter: Michaela B Kirschner
- Abstract
Loading... -
+
MA06.07 - Discussant
14:35 - 14:40 | Presenter: Rabab Mohamed Gaafar
- Abstract
No abstract available for this presentation
-
+
MA06.08 - A Safety Study of Avelumab plus SBRT in Malignant Mesothelioma
14:40 - 14:45 | Presenter: Andreas Rimner
- Abstract
Loading... -
+
MA06.09 - Preliminary Safety, Efficacy Results of KN046 (Bispecific Anti-PD-L1/CTLA4) in Subjects With Rare Thoracic Tumors
14:45 - 14:50 | Presenter: Gary Richardson
- Abstract
Loading... -
+
MA06.10 - A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
14:50 - 14:55 | Presenter: Margaret Ottaviano
- Abstract
Loading... -
+
MA06.11 - The Collision of Good Syndrome and Autoimmunity in Thymic Epithelial Tumors
14:55 - 15:00 | Presenter: Giovannella Palmieri
- Abstract
Loading... -
+
MA06.12 - Discussant
15:00 - 15:05 | Presenter: Jan Hinrich von der Thüsen
- Abstract
No abstract available for this presentation
-
+
MA06.13 - Live Q&A
15:05 - 15:15
- Abstract
No abstract available for this presentation
-
+
ES17 - The New WHO Classification of Lung Tumors
- 15:30 - 16:30
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
-
+
ES17.01 - Chair
15:30 - 15:30 | Presenter: Ming Sound Tsao
- Abstract
Loading... -
+
ES17.02 - Chair
15:30 - 15:30 | Presenter: Dong-Mei Lin
- Abstract
No abstract available for this presentation
-
+
ES17.03 - Updates in Squamous Cell Carcinoma and Neuroendocrine Tumors of the Lung
15:30 - 15:42 | Presenter: Andrew Gordon Nicholson
- Abstract
Loading... -
+
ES17.04 - Updates in Mesothelioma
15:42 - 15:54 | Presenter: Sanja Dacic
- Abstract
Loading... -
+
ES17.05 - Updates in Lung Adenocarcinoma, Mucinous and Non-mucinous
15:54 - 16:06 | Presenter: Keith M Kerr
- Abstract
No abstract available for this presentation
-
+
ES17.06 - Updates in Molecular Pathology and Genomics of Lung Tumors
16:06 - 16:18 | Presenter: Yasushi Yatabe
- Abstract
Loading... -
+
ES17.07 - Live Q&A
16:18 - 16:30
- Abstract
No abstract available for this presentation
-
+
MA07 - Improving Care for People with Lung Cancer: Decision Making, Survivorship, and New Challenges During COVID-19
- 15:30 - 16:30
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Patient Advocacy
-
+
MA07.01 - How Lung Cancer Patients Perceive their Treating Doctors and Engage in medical decision-making: Lessons from Project PRIORITY
15:30 - 15:35 | Presenter: Jill Feldman
- Abstract
Loading... -
+
MA07.02 - Are People with Lung Cancer Satisfied with the Care they Receive?
15:35 - 15:40 | Presenter: Yvonne Nartey
- Abstract
Loading... -
+
MA07.03 - Current Practice of Lung Cancer Survivorship Care: Is a Care Plan Enough?
15:40 - 15:45 | Presenter: Hina Khan
- Abstract
Loading... -
+
MA07.04 - Breathe Anew: Designing and Testing the Feasibility of a Novel Intervention for Lung Cancer Survivorship
15:45 - 15:50 | Presenter: Yogita S Patel
- Abstract
Loading... -
+
MA07.05 - Survivors from Anti-PD-(L)1 Immunotherapy in NSCLC: Clinical Features, Survival Outcomes and Long-term Toxicities
15:50 - 15:55 | Presenter: Melinda Hsu
- Abstract
Loading... -
+
MA07.06 - Discussant
15:55 - 16:07 | Presenter: Haryana M. Dhillon
- Abstract
No abstract available for this presentation
-
+
MA07.07 - Assessing the Impact of the COVID-19 Pandemic on Patient Advocacy and Support Organisations
16:07 - 16:12 | Presenter: Matthew Peters
- Abstract
Loading... -
+
MA07.08 - Needs Assessment of Lung Cancer Patients & Caregivers in the Post-Shelter-in-Place Era in the United States during COVID-19
16:12 - 16:17 | Presenter: Jessica Selig
- Abstract
Loading... -
+
MA07.09 - Lung Cancer Patients Survey Under COVID-19 Epidemic
16:17 - 16:22 | Presenter: Kazuo Hasegawa
- Abstract
Loading... -
+
MA07.10 - Discussant
16:22 - 16:30 | Presenter: Amy C. Moore
- Abstract
No abstract available for this presentation
-
+
OA09 - Mesothelioma from Pathogenesis to Therapy
- 15:30 - 16:30
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
OA09.01 - Chair
15:30 - 15:30 | Presenter: Bruce Robinson
- Abstract
No abstract available for this presentation
-
+
OA09.02 - Chair
15:30 - 15:30 | Presenter: Steven Kao
- Abstract
No abstract available for this presentation
-
+
OA09.03 - MESOMICS Project: Molecular Characterization of Malignant Pleural Mesothelioma Using a Multi-Omic Approach
15:30 - 15:40 | Presenter: Lise Mangiante
- Abstract
Loading... -
+
OA09.04 - The Course of the Risk of Mesothelioma in Karain Cohort With Erionite Exposure Living in Stockholm: No Erionite Exposure No Mesothelioma
15:40 - 15:50 | Presenter: MUZAFFER METINTAS
- Abstract
Loading... -
+
OA09.05 - Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Physician’s Choice of First-line Platinum Chemotherapy
15:50 - 16:00 | Presenter: Kathleen Claire Kerrigan
- Abstract
Loading... -
+
OA09.06 - Nivolumab in Recurrent Malignant Pleural Mesothelioma: Real-World Data From Expanded Access Program In The Netherlands
16:00 - 16:10 | Presenter: Robert Anton Belderbos
- Abstract
Loading... -
+
OA09.07 - Discussant
16:10 - 16:20 | Presenter: Thomas John
- Abstract
No abstract available for this presentation
-
+
OA09.08 - Live Q&A
16:20 - 16:30
- Abstract
No abstract available for this presentation
-
+
ES18 - The Future of Immunotherapy in Unresectable Mesothelioma
- 16:45 - 17:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
ES18.01 - Immunotherapy – Current State of Play (Concentrating on Current Data for First Line and Salvage Strategies)
16:45 - 17:00 | Presenter: Sanjay Popat
- Abstract
Loading... -
+
ES18.02 - Molecular Profiling as Biomarker for Checkpoint Inhibitors in Mesothelioma
17:00 - 17:15 | Presenter: Nicola Jane Waddell
- Abstract
No abstract available for this presentation
-
+
ES18.03 - Checkpoint Inhibitors – How to Combine and Which Combination is Most Promising
17:15 - 17:30 | Presenter: Anna Katherine Nowak
- Abstract
No abstract available for this presentation
-
+
ES18.04 - BAP1 as a Biomarker - Implications for Treatment (Including Immunotherapy)
17:30 - 17:45 | Presenter: Michele Carbone
- Abstract
No abstract available for this presentation
-
+
ES19 - Patient-Reported Outcomes, Patient Registries and Real-World Evidence: Learning Directly from Patients
- 16:45 - 17:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Patient Advocacy
-
+
ES19.01 - Chair
16:45 - 16:45 | Presenter: Catherine Holliday
- Abstract
No abstract available for this presentation
-
+
ES19.02 - Chair
16:45 - 16:45 | Presenter: Vanessa Beattie
- Abstract
No abstract available for this presentation
-
+
ES19.03 - Understanding the Feasibility of Patient Reported Outcomes
16:45 - 17:00 | Presenter: Karla Gough
- Abstract
Loading... -
+
ES19.04 - Improving Lung Cancer Survival Through Tracking of Patient Reported Outcomes
17:00 - 17:15 | Presenter: Massimo Di Maio
- Abstract
Loading... -
+
ES19.05 - Incorporating Patient Reported Outcomes into the Lung Cancer Registry
17:15 - 17:30 | Presenter: Jennifer C. King
- Abstract
Loading... -
+
ES19.06 - Live Q&A
17:30 - 17:45
- Abstract
No abstract available for this presentation
-
+
MA08 - Advances in Biomarkers for Immune Checkpoint Blockade and Targeted Therapy in Non Small Cell Lung Carcinoma
- 16:45 - 17:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
-
+
MA08.01 - Chair
16:45 - 16:45 | Presenter: Keith M Kerr
- Abstract
No abstract available for this presentation
-
+
MA08.02 - Chair
16:45 - 16:45 | Presenter: Teh-Ying Chou
- Abstract
No abstract available for this presentation
-
+
MA08.03 - Immunotherapy Alone or with Chemotherapy in Advanced NSCLC? Utility of Clinical Factors and Blood-Based Host Immune Profiling
16:45 - 16:50 | Presenter: Wallace Akerley
- Abstract
Loading... -
+
MA08.04 - LIPI and Outcomes of Durvalumab as Consolidation Therapy after ChRT in Patients with Locally-Advanced NSCLC
16:50 - 16:55 | Presenter: Mariona Riudavets
- Abstract
Loading... -
+
MA08.05 - High Concordance in Scoring PD-L1 in NSCLC Using the Roche Digital Pathology uPath system and PD-L1 Assessment Algorithm
16:55 - 17:00 | Presenter: Alexander Haragan
- Abstract
Loading... -
+
MA08.06 - Stratifying PD-L1 Expression Level Based on Multimodal Genomic Features for the Prediction of Immunotherapy Benefit in NSCLC
17:00 - 17:05 | Presenter: Yue Li
- Abstract
Loading... -
+
MA08.07 - Discussant
17:05 - 17:10 | Presenter: Wendy Cooper
- Abstract
No abstract available for this presentation
-
+
MA08.08 - Implementation of Diagnostic Biomarker Testing in Lung Cancer: Real-World Data in Japan
17:10 - 17:15 | Presenter: Yasushi Yatabe
- Abstract
Loading... -
+
MA08.09 - Clinical Management of Lung Adenocarcinoma Patients With HER2 V659E Mutation
17:15 - 17:20 | Presenter: Ziqi Jia
- Abstract
Loading... -
+
MA08.10 - LUNGMAP Master Protocol (LUNGMAP): Concordance Between Plasma ctDNA and Tissue Molecular Analysis
17:20 - 17:25 | Presenter: Philip Christopher Mack
- Abstract
Loading... -
+
MA08.11 - Identification of Clinical Features to Predict the Consistency of Mutational Profiles Obtained From Plasma and Tissue of Advanced NSCLC Patient
17:25 - 17:30 | Presenter: Yuansheng Zang
- Abstract
Loading... -
+
MA08.12 - Discussant
17:30 - 17:35 | Presenter: Lukas Bubendorf
- Abstract
No abstract available for this presentation
-
+
MA08.13 - Live Q&A
17:35 - 17:45
- Abstract
No abstract available for this presentation
-
+
PS02 - Presidential Symposium (Re-Broadcast) (Japanese, Mandarin, Spanish Translation Available)
- 18:00 - 20:00
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
-
+
PS02.01 - Welcome Video
18:00 - 18:02
- Abstract
No abstract available for this presentation
-
+
PS02.02 - National Lung Cancer Screening Program in Taiwan: The TALENT Study
18:02 - 18:12 | Presenter: Pan-Chyr Yang
- Abstract
Loading... -
+
PS02.03 - Discussant
18:12 - 18:20 | Presenter: Ugo Pastorino
- Abstract
No abstract available for this presentation
-
+
PS02.04 - International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results
18:20 - 18:30 | Presenter: Silvia Novello
- Abstract
Loading... -
+
PS02.05 - Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
18:30 - 18:40 | Presenter: Jay M. Lee
- Abstract
Loading... -
+
PS02.06 - Discussant
18:40 - 18:50 | Presenter: Shinichi Toyooka
- Abstract
No abstract available for this presentation
-
+
PS02.07 - CodeBreaK 100: Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutated Non-small Cell Lung Cancer
18:50 - 19:00 | Presenter: Bob T. Li
- Abstract
Loading... -
+
PS02.08 - Discussant
19:00 - 19:08 | Presenter: Pasi Antero Jänne
- Abstract
No abstract available for this presentation
-
+
PS02.09 - Pembrolizumab Plus Ipilimumab vs Pembrolizumab Plus Placebo as 1L Therapy for Metastatic NSCLC of PD-L1 TPS ≥50%: KEYNOTE-598
19:08 - 19:18 | Presenter: Michael Boyer
- Abstract
Loading... -
+
PS02.10 - Discussant
19:18 - 19:26 | Presenter: Yun Fan
- Abstract
No abstract available for this presentation
-
+
PS02.11 - Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial
19:26 - 19:36 | Presenter: Dean Fennell
- Abstract
Loading... -
+
PS02.12 - Discussant
19:36 - 19:44 | Presenter: Rina Hui
- Abstract
No abstract available for this presentation
-
+
PS02.13 - Live Q&A
19:44 - 20:00
- Abstract
No abstract available for this presentation
-
+
PS02.14 - Chair
18:00 - 18:00 | Presenter: Tetsuya Mitsudomi
- Abstract
No abstract available for this presentation
-
+
PL04 - A Vision for Clinical Trials in 2020 and Beyond (Japanese, Mandarin, Spanish Translation Available)
- 07:00 - 09:00
- 1/31/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
-
+
PL04.01 - Chair
07:00 - 07:00 | Presenter: Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
PL04.02 - Chair
07:00 - 07:00 | Presenter: Myung-Ju Ahn
- Abstract
No abstract available for this presentation
-
+
PL04.03 - Evolving Challenges in Drug Development
07:00 - 07:15 | Presenter: Bruce E. Johnson
- Abstract
Loading... -
+
PL04.04 - Implementing New Paradigms for Delivering Radiation Therapy in the Clinic
07:15 - 07:30 | Presenter: Billy W Loo
- Abstract
Loading... -
+
PL04.05 - Uptake of RWD and RWE in Clinical Trial Design
07:30 - 07:45 | Presenter: Xiaoyuan Chen
- Abstract
No abstract available for this presentation
-
+
PL04.06 - Diversifying Clinical Trial Inclusion Criteria: Current Challenges and Potential Solutions
07:45 - 08:00 | Presenter: Jill Feldman
- Abstract
No abstract available for this presentation
-
+
PL04.07 - Looking Into the Future of Drug Development
08:00 - 08:15 | Presenter: Jean Charles Soria
- Abstract
No abstract available for this presentation
-
+
PL04.08 - The Future of Clinical Trials - The Surgical Perspective
08:15 - 08:30 | Presenter: Masahiro Tsuboi
- Abstract
No abstract available for this presentation
-
+
PL04.09 - Live Q&A
08:30 - 09:00
- Abstract
No abstract available for this presentation
first
prev
